Tag: Cancer: Ovarian
Niraparib Extends Time Without Symptoms in Ovarian Cancer
Findings based on phase 3 study of maintenance therapy with PARP inhibitor following treatment
Lymphadenectomy Does Not Up Survival in Advanced Ovarian Cancer
Findings seen after intra-abdominal macroscopically complete resection with normal lymph nodes
U.S. Agencies Probing Johnson & Johnson Over Asbestos in Talc
Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma
Artificial Intelligence Predicts Survival in Epithelial Ovarian Cancer
Radiomic Prognostic Vector IDs patients with median overall survival of less than two years
Conservative Management Feasible for Adnexal Masses
Risk for malignancy, acute complications low for adnexal mass with benign ultrasound morphology
Many Women Have Not Heard of Ovarian Cancer Before Dx
Nine in 10 women experience multiple symptoms prediagnosis; eight in 10 of them consult a doctor
Low-Dose Aspirin May Reduce Ovarian Cancer Risk
Inverse association for low-dose but not standard-dose aspirin with ovarian cancer risk
Newer Hormonal Contraception May Cut Ovarian Cancer Risk
Combined hormonal contraception use tied to lower risk; risk down with increasing duration of use
Link for Asbestos-Free Talcum Powder, Cancer Not Clear
Studies conducted in people have mixed results, with some indication of increased risk of ovarian cancer
Jury Awards $4.62B in Johnson & Johnson Talcum Powder Lawsuit
The award includes $550 million in compensatory damages and $4.14 billion in punitive damages
